{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/patient-perspectives-car-t-therapy-clinical-trial-setting#webpage",
"url": "https://www.fortrea.com/insights/patient-perspectives-car-t-therapy-clinical-trial-setting",
"name": "Patient perspectives on CAR-T therapy clinical trial setting",
"description": "This Fortrea white paper explores patient perspectives in CAR-T therapy clinical trials and the growing importance of patient-centered approaches across cell therapy research programs. The content focuses on CAR-T therapy clinical trials, patient perspectives, patient experience, treatment journey considerations, patient support strategies, and CAR-T clinical development approaches associated with advanced cell therapy research. The white paper highlights factors related to treatment accessibility, patient communication, emotional and logistical support, treatment pathway understanding, and patient engagement approaches affecting CAR-T therapy clinical trial participation. Fortrea discusses patient-centered and operational perspectives designed to support patient experience strategies, strengthen engagement approaches, and improve participation experiences across CAR-T therapy clinical trials. By integrating patient perspectives with treatment journey considerations and CAR-T clinical development strategies, the white paper provides insights into patient-centered approaches affecting CAR-T therapy clinical trials and broader cell therapy research environments"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Patient perspectives on CAR-T therapy clinical trial setting",
"item": "https://www.fortrea.com/insights/patient-perspectives-car-t-therapy-clinical-trial-setting"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/patient-perspectives-car-t-therapy-clinical-trial-setting#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/patient-perspectives-car-t-therapy-clinical-trial-setting#webpage"
},
"headline": "CAR-T Clinical Trial Experiences and Patient-Centered Research Strategies | Fortrea White Paper",
"description": "This Fortrea white paper explores patient perspectives in CAR-T therapy clinical trials and the growing importance of patient-centered approaches across cell therapy research programs. The content focuses on CAR-T therapy clinical trials, patient perspectives, patient experience, treatment journey considerations, patient support strategies, and CAR-T clinical development approaches associated with advanced cell therapy research. The white paper highlights factors related to treatment accessibility, patient communication, emotional and logistical support, treatment pathway understanding, and patient engagement approaches affecting CAR-T therapy clinical trial participation. Fortrea discusses patient-centered and operational perspectives designed to support patient experience strategies, strengthen engagement approaches, and improve participation experiences across CAR-T therapy clinical trials. By integrating patient perspectives with treatment journey considerations and CAR-T clinical development strategies, the white paper provides insights into patient-centered approaches affecting CAR-T therapy clinical trials and broader cell therapy research environments",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-12-17",
"dateModified": "2025-12-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-12/patient-perspectives-on-car-t-therapy-clinical-trial-setting.pdf",
"encodingFormat": "application/pdf"
}
}
]
}